Skip to main content

Peer Review reports

From: Epigenomic perturbation of novel EGFR enhancers reduces the proliferative and invasive capacity of glioblastoma and increases sensitivity to temozolomide

Original Submission
23 Mar 2023 Submitted Original manuscript
15 May 2023 Reviewed Reviewer Report
1 Jun 2023 Reviewed Reviewer Report
30 Aug 2023 Author responded Author comments - Silvia Remeseiro
Resubmission - Version 2
30 Aug 2023 Submitted Manuscript version 2
7 Sep 2023 Author responded Author comments - Silvia Remeseiro
Resubmission - Version 3
7 Sep 2023 Submitted Manuscript version 3
12 Sep 2023 Author responded Author comments - Silvia Remeseiro
Resubmission - Version 4
12 Sep 2023 Submitted Manuscript version 4
14 Sep 2023 Reviewed Reviewer Report
17 Sep 2023 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
18 Sep 2023 Editorially accepted
6 Oct 2023 Article published 10.1186/s12885-023-11418-9

You can find further information about peer review here.

Back to article page